Skip to main content
Toggle navigation
Search
Home
Cardiovascular
Home
Cardiovascular
Cardiovascular
Type here to filter the list
(30) Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry
(31) Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
(32) Impact of switching from high- to low-sodium oxybate on ambulatory blood pressure in people with narcolepsy
(33) Economic burden associated with systemic inflammation in patients with established atherosclerotic cardiovascular disease and stage 3-4 chronic kidney disease
(34) Short-term impact on healthcare costs after modification to PCSK9i therapy clinical criteria
(35) Descriptive Analysis of ATTR-CM Patients Enrolled in Medicare Advantage.
(36) Descriptive Analysis of ATTR-CM Patients Initiating Tafamidis Among Medicare Advantage Enrollees.
(37) Healthcare Costs and Delays in Treatment Escalation in Hypertension Patients in the United States: Results from the BREAKTHROUGH Real-World Study
(38) Payer analysis of cholesterol management in US individuals with atherosclerotic cardiovascular disease during 2023: A study from the Family Heart Database®
(39) Treatment, Testing, and Outcomes from ST-elevation Myocardial Infarction (STEMI) at an Academic Healthcare System: A Retrospective Analysis
(40) Retrospective analysis of cardiovascular, renal, and metabolic conditions in the Medicare population using 100% FFS claims data
(41) Olezarsen and plozasiran in the treatment of familial chylomicronemia syndrome (FCS): Results from a matching-adjusted indirect comparison (MAIC)
